PUBLICATION

SMC Laboratories is highly regarded worldwide as a consulting CRO that designs studies in line with the demands of pharmaceutical companies and research institutions.
In particular, in the NASH-HCC field, SMC is a highly regarded CRO, because of our unique STAM™ mice.
The results achieved with our STAM™ have been introduced in academic publications as well as scientific conferences.

Publications

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

No.85

2024

Sci Rep.,

“Periodontitis promotes hepatocellular carcinoma in Stelic Animal model (STAM) mice” (Sci. Rep., DOI: 10.1038/s41598-024-68422-7, 2024)

VIEW ARTICLE bug

No.84

2024

Am J Physiol Gastrointest Liver Physiol.,

“StarD5 levels of expression correlate with onset and progression of steatosis and liver fibrosis” (Am J Physiol Gastrointest Liver Physiol., DOI: 10.1152/ajpgi.00024.2024, 2024)

VIEW ARTICLE bug

No.83

2024

Nat.Biotechnol,

“A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models” (Nat Biotechnol., DOI: 10.1038/s41587-024-02143-0, 2024)

VIEW ARTICLE bug